In Vitro Methods to Support Transporter Evaluation in Drug Discovery and Development
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
In Vitro Methods to Support Transporter Evaluation in Drug Discovery and Development
Authors
Keywords
-
Journal
CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume 94, Issue 1, Pages 95-112
Publisher
Springer Nature
Online
2013-04-15
DOI
10.1038/clpt.2013.81
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Intracellular Drug Concentrations and Transporters: Measurement, Modeling, and Implications for the Liver
- (2013) X Chu et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Transporter Studies in Drug Development: Experience to Date and Follow-Up on Decision Trees From the International Transporter Consortium
- (2013) D Tweedie et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- ITC Recommendations for Transporter Kinetic Parameter Estimation and Translational Modeling of Transport-Mediated PK and DDIs in Humans
- (2013) M J Zamek-Gliszczynski et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Hepatic and Intestinal Drug Transporters: Prediction of Pharmacokinetic Effects Caused by Drug-Drug Interactions and Genetic Polymorphisms
- (2012) Kenta Yoshida et al. Annual Review of Pharmacology and Toxicology
- The UCSF-FDA TransPortal: A Public Drug Transporter Database
- (2012) K M Morrissey et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Highlights from the International Transporter Consortium Second Workshop
- (2012) M J Zamek-Gliszczynski et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Long-lasting Inhibitory Effects of Cyclosporin A, but Not Tacrolimus, on OATP1B1- and OATP1B3-mediated Uptake
- (2012) Yoshihisa Shitara et al. Drug Metabolism and Pharmacokinetics
- Species differences in drug transporters and implications for translating preclinical findings to humans
- (2012) Xiaoyan Chu et al. Expert Opinion on Drug Metabolism & Toxicology
- The Role of BCS (Biopharmaceutics Classification System) and BDDCS (Biopharmaceutics Drug Disposition Classification System) in Drug Development
- (2012) Leslie Z. Benet JOURNAL OF PHARMACEUTICAL SCIENCES
- Importance of the multidrug and toxin extrusion MATE/SLC47A family to pharmacokinetics, pharmacodynamics/toxicodynamics and pharmacogenomics
- (2011) Atsushi Yonezawa et al. BRITISH JOURNAL OF PHARMACOLOGY
- Variations in ATP-Binding Cassette Transporter Regulation during the Progression of Human Nonalcoholic Fatty Liver Disease
- (2011) R. N. Hardwick et al. DRUG METABOLISM AND DISPOSITION
- Kinetic Characterization of Rat Hepatic Uptake of 16 Actively Transported Drugs
- (2011) Y. Yabe et al. DRUG METABOLISM AND DISPOSITION
- Drug-permeability and transporter assays in Caco-2 and MDCK cell lines
- (2011) Donna A Volpe Future Medicinal Chemistry
- Sandwich-cultured hepatocytes: anin vitromodel to evaluate hepatobiliary transporter-based drug interactions and hepatotoxicity
- (2010) Brandon Swift* et al. DRUG METABOLISM REVIEWS
- Transporters involved in the hepatic uptake of 99mTc-mebrofenin and indocyanine green
- (2010) Wilmar de Graaf et al. JOURNAL OF HEPATOLOGY
- Improved Extrapolation of Hepatobiliary Clearance fromin VitroSandwich Cultured Rat Hepatocytes through Absolute Quantification of Hepatobiliary Transporters
- (2010) Na Li et al. MOLECULAR PHARMACEUTICS
- Membrane transporters in drug development
- (2010) NATURE REVIEWS DRUG DISCOVERY
- Interference with Bile Salt Export Pump Function Is a Susceptibility Factor for Human Liver Injury in Drug Development
- (2010) Ryan E. Morgan et al. TOXICOLOGICAL SCIENCES
- If the KI Is Defined by the Free Energy of Binding to P-Glycoprotein, Which Kinetic Parameters Define the IC50 for the Madin-Darby Canine Kidney II Cell Line Overexpressing Human Multidrug Resistance 1 Confluent Cell Monolayer?
- (2009) A. A. Lumen et al. DRUG METABOLISM AND DISPOSITION
- Endogenous Gene and Protein Expression of Drug-Transporting Proteins in Cell Lines Routinely Used in Drug Discovery Programs
- (2009) G. Ahlin et al. DRUG METABOLISM AND DISPOSITION
- Hepatobiliary Disposition of Troglitazone and Metabolites in Rat and Human Sandwich-Cultured Hepatocytes: Use of Monte Carlo Simulations to Assess the Impact of Changes in Biliary Excretion on Troglitazone Sulfate Accumulation
- (2009) J. K. Lee et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Effect of Plasma Protein Binding on in Vitro-in Vivo Correlation of Biliary Excretion of Drugs Evaluated by Sandwich-Cultured Rat Hepatocytes
- (2008) H. Fukuda et al. DRUG METABOLISM AND DISPOSITION
- Use of Sandwich-Cultured Human Hepatocytes to Predict Biliary Clearance of Angiotensin II Receptor Blockers and HMG-CoA Reductase Inhibitors
- (2008) K. Abe et al. DRUG METABOLISM AND DISPOSITION
- Identification of interspecies difference in efflux transporters of hepatocytes from dog, rat, monkey and human
- (2008) Meng Li et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Comparison of drug transporter gene expression and functionality in Caco-2 cells from 10 different laboratories
- (2008) Rose Hayeshi et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- In Vitro Biliary Clearance of Angiotensin II Receptor Blockers and 3-Hydroxy-3-methylglutaryl-Coenzyme A Reductase Inhibitors in Sandwich-Cultured Rat Hepatocytes: Comparison with in Vivo Biliary Clearance
- (2008) K. Abe et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Biopharmaceutics Classification System: Validation and Learnings of an in Vitro Permeability Assay
- (2008) Victoria E. Thiel-Demby et al. MOLECULAR PHARMACEUTICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started